Methyl 2-{[(2-{[2-(2,5-dimethoxyphenyl)quinolin-4-yl]carbonyl}hydrazinyl)carbonothioyl]amino}-5-phenylthiophene-3-carboxylate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: Methyl 2-{[(2-{[2-(2,5-dimethoxyphenyl)quinolin-4-yl]carbonyl}hydrazinyl)carbonothioyl]amino}-5-phenylthiophene-3-carboxylate
• 英文别名: methyl 2-[[[2-(2,5-dimethoxyphenyl)quinoline-4-carbonyl]amino]carbamothioylamino]-5-phenylthiophene-3-carboxylate
• 化学式: C₃₁H₂₆N₄O₅S₂
• 分子量: 598.7
• InChiKey: WFQAPWXEIGRVOJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.6
• 重原子数：
  42
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  171
• 氢给体数：
  3
• 氢受体数：
  8

文献信息

• Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors
  申请人：Schwartz Michael

  公开号：US20100297046A1

  公开（公告）日：2010-11-25

  The invention relates to compounds and methods for inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin, by way of fructosamine-3-kinase inhibition, thereby treating or prevention various diseases, disorders or conditions. Additionally, the invention relates to treatment of various diseases, disorders or conditions associated with or mediated by oxidative stress since 3DG induces ROS and AGEs, which are associated with the inflammatory response caused by oxidative stress.